Market Cap: $16.03M
LI
Lisata Therapeutics, Inc.
LSTA
NASDAQ (NASDAQ Capital Market)USD
Market Cap: $16.03M
Lisata deal draws scrutiny over cash-plus-CVR structure and board duties Halper Sadeh LLC is investigating Lisata Therapeutics’ proposed sale to Kuva Labs, flagging potential breaches of fiduciary dut…
Lisata–Kuva deal draws legal scrutiny over contingent‑value structure Investor‑rights firm Halper Sadeh LLC is investigating Lisata Therapeutics’ proposed sale to Kuva Labs after shareholders are offe…
Investor law firm challenges Lisata-Kuva terms amid scrutiny of biotech deal Halper Sadeh LLC is probing Lisata Therapeutics’ proposed sale to Kuva Labs, raising concerns that the transaction’s struct…
Harbour BioMed Strengthens Collaborative Ties with Spruce Biosciences Harbour BioMed, a biopharmaceutical company specializing in novel antibody therapeutics, announces a significant development in it…
Harbour BioMed Strengthens Ties with Spruce Biosciences Through Strategic Acquisition Harbour BioMed announces a significant development in its collaboration with Spruce Biosciences by exercising its…
Neurocrine Biosciences Highlights VMAT2 Occupancy in Movement Disorder Treatments Recent findings presented by Neurocrine Biosciences, Inc. at the American College of Neuropsychopharmacology’s 64th An…
Neurocrine Biosciences Highlights INGREZZA's Potency in Treating Movement Disorders Neurocrine Biosciences, Inc. presents promising findings from a recent study that could reshape treatment approaches…
IDEAYA Biosciences Focuses on Precision Oncology in 2026 Initiatives IDEAYA Biosciences, Inc. is setting ambitious goals as it advances its precision medicine oncology initiatives. During the 44th Ann…
Innovations in Precision Medicine: Alamar Biosciences' Strategic Growth Alamar Biosciences, Inc. is making significant strides in the precision medicine sector through its recent financing and leaders…
Innovative Collaborations in Biotech: Nona Biosciences Partners with Link Cell Therapies Nona Biosciences, a biotechnology firm based in Cambridge, Massachusetts, embarks on a significant collaboratio…
Strategic Collaboration Paves the Way for Innovative Remyelination Therapies Evogene Ltd. and Unravel Biosciences, Inc. have recently announced a strategic partnership aimed at developing groundbreaki…
Lisata Therapeutics: Pioneering Remyelination Therapies in Neurological Disorders Lisata Therapeutics is at the forefront of developing innovative therapies for demyelinating diseases, particularly Mu…
Advancing Precision Oncology: IDEAYA Biosciences Prepares for Key Presentation IDEAYA Biosciences, Inc. is poised to make a significant impact in the field of precision medicine at the upcoming 44th A…
Innovative Cancer Therapies: IDEAYA Biosciences Prepares for J.P. Morgan Healthcare Conference IDEAYA Biosciences, a leader in precision medicine for oncology, is set to present at the 44th Annual J.P…
### Advancing Precision Oncology: IDEAYA Biosciences at the Forefront of Cancer Treatment Innovations IDEAYA Biosciences, Inc. participates in the upcoming 44th Annual J.P. Morgan Healthcare Conferenc…
Pioneering Advances in Oncology: Senhwa Biosciences’ Pidnarulex Trial Senhwa Biosciences, Inc. is making significant strides in oncology research with its Phase 1b clinical trial of the investigationa…
Innovative Oncology Advances: Senhwa Biosciences’ Pidnarulex Combines with Enhertu for HER2-Positive Tumors Senhwa Biosciences, Inc. makes significant strides in oncology with its investigational drug…
Senhwa Biosciences Advances Cancer Treatment with Pidnarulex and Trastuzumab Deruxtecan Combination Senhwa Biosciences, Inc. achieves a significant milestone in oncology research with its Phase 1b cli…
Nona Biosciences Expands Framework to Enhance Early Clinical Development Nona Biosciences, a prominent biotechnology company from Cambridge, Massachusetts, is expanding its integrated discovery and de…
Datma and Rhythm Biosciences Forge Alliance to Enhance Cancer Risk Prediction Tools In a significant development within the healthcare landscape, datma, a leader in federated real-world data access, a…
Datma and Rhythm Biosciences Forge Strategic Alliance to Enhance Cancer Risk Prediction Tools In a significant development within the realm of cancer diagnostics, datma, a leader in federated real-wor…
Leveraging AI to Transform COPD Drug Development Lisata Therapeutics operates in an increasingly complex landscape of biotechnology where real-world data and artificial intelligence (AI) are becoming…
Nona Biosciences and Valink Therapeutics Forge Strategic Alliance to Enhance Cancer Therapies In a significant development within the biotechnology sector, Nona Biosciences has established a strategic…
Neurocrine Biosciences Redefines R&D Strategy with Focus on Innovative Therapeutics Neurocrine Biosciences, Inc. is undergoing a significant transformation in its research and development strategy, em…
TuHURA Biosciences Advances Cancer Immunotherapy with Strategic Developments TuHURA Biosciences, Inc. is making significant strides in the field of immuno-oncology, focusing on innovative therapies de…